A breakthrough case study showing how 8 weeks of sofosbuvir/ledipasvir cured hepatitis C in a 4-year-old child, revolutionizing pediatric HCV treatment.
Breakthrough research on using sofosbuvir/velpatasvir (SOF/VEL) to treat Hepatitis C in pregnant women and prevent mother-to-child transmission.
Explore how sofosbuvir, pegylated-interferon and ribavirin combination therapy revolutionized Hepatitis C treatment for genotype 1 infection.